Helicases DDX5 and DDX17 promote heterogeneity in HBV transcription termination in infected human hepatocytes

Autor: Chapus, Fleur, Giraud, Guillaume, Huchon, Pélagie, Rodà, Mélanie, Grand, Xavier, Charre, Caroline, Goldsmith, Chloé, Roca Suarez, Armando Andres, Martinez, Maria-Guadalupe, Fresquet, Judith, Diederichs, Audrey, Locatelli, Maëlle, Polvèche, Hélène, Scholtès, Caroline, Chemin, Isabelle, Hernandez Vargas, Hector, Rivoire, Michel, Bourgeois, Cyril F., Zoulim, Fabien, Testoni, Barbara

Publikováno v: In Journal of Hepatology October 2024 81(4):609-620

G-quadruplexes control hepatitis B virus replication by promoting cccDNA transcription and phase separation in hepatocytes.

Autor: Giraud, Guillaume, Rodà, Mélanie, Huchon, Pélagie, Michelet, Maud, Maadadi, Sarah, Jutzi, Daniel, Montserret, Roland, Ruepp, Marc-David, Parent, Romain, Combet, Christophe, Zoulim, Fabien, Testoni, Barbara

Publikováno v: Nucleic Acids Research; 3/21/2024, Vol. 52 Issue 5, p2290-2305, 16p

Protocol for isolating CD163 ⁺ Kupffer cells from human liver resections.

Autor: Roca Suarez AA; INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France; University of Lyon, Université Claude-Bernard (UCBL), Lyon, France; The Lyon Hepatology Institute EVEREST, Lyon, France. Electronic address: armando-andres.roca-suarez@inserm.fr., Plissonnier ML; INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France; University of Lyon, Université Claude-Bernard (UCBL), Lyon, France; The Lyon Hepatology Institute EVEREST, Lyon, France., Michelet M; INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France; University of Lyon, Université Claude-Bernard (UCBL), Lyon, France; The Lyon Hepatology Institute EVEREST, Lyon, France., Dubois A; INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France; University of Lyon, Université Claude-Bernard (UCBL), Lyon, France; The Lyon Hepatology Institute EVEREST, Lyon, France., Heintz S; INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France; University of Lyon, Université Claude-Bernard (UCBL), Lyon, France; The Lyon Hepatology Institute EVEREST, Lyon, France., Saez-Palma M; INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France; University of Lyon, Université Claude-Bernard (UCBL), Lyon, France; The Lyon Hepatology Institute EVEREST, Lyon, France., Delphin M; The Francis Crick Institute, London, UK., Bordes I; INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France; University of Lyon, Université Claude-Bernard (UCBL), Lyon, France; The Lyon Hepatology Institute EVEREST, Lyon, France., Molle J; INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France; University of Lyon, Université Claude-Bernard (UCBL), Lyon, France; The Lyon Hepatology Institute EVEREST, Lyon, France., Diederichs A; INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France; University of Lyon, Université Claude-Bernard (UCBL), Lyon, France; The Lyon Hepatology Institute EVEREST, Lyon, France., Rodà M; INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France; University of Lyon, Université Claude-Bernard (UCBL), Lyon, France; The Lyon Hepatology Institute EVEREST, Lyon, France., Combe E; INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France; University of Lyon, Université Claude-Bernard (UCBL), Lyon, France; The Lyon Hepatology Institute EVEREST, Lyon, France., Mougené L; INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France; University of Lyon, Université Claude-Bernard (UCBL), Lyon, France; The Lyon Hepatology Institute EVEREST, Lyon, France., Giraud G; INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France; University of Lyon, Université Claude-Bernard (UCBL), Lyon, France; The Lyon Hepatology Institute EVEREST, Lyon, France., Grand X; INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France; University of Lyon, Université Claude-Bernard (UCBL), Lyon, France; The Lyon Hepatology Institute EVEREST, Lyon, France., Rivoire M; The Lyon Hepatology Institute EVEREST, Lyon, France; INSERM U1032, Centre Léon Bérard (CLB), 69008 Lyon, France., Levrero M; INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France; University of Lyon, Université Claude-Bernard (UCBL), Lyon, France; The Lyon Hepatology Institute EVEREST, Lyon, France; Department of Hepatology, Croix Rousse Hospital, Hospices Civils de Lyon, Lyon, France; Department of Internal Medicine - DMISM and the IIT Center for Life Nanoscience (CLNS), Sapienza University, Rome, Italy., Testoni B; INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France; University of Lyon, Université Claude-Bernard (UCBL), Lyon, France; The Lyon Hepatology Institute EVEREST, Lyon, France. Electronic address: barbara.testoni@inserm.fr., Zoulim F; INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France; University of Lyon, Université Claude-Bernard (UCBL), Lyon, France; The Lyon Hepatology Institute EVEREST, Lyon, France; Department of Hepatology, Croix Rousse Hospital, Hospices Civils de Lyon, Lyon, France. Electronic address: fabien.zoulim@inserm.fr.

Publikováno v: STAR protocols [STAR Protoc] 2024 Oct 04; Vol. 5 (4), pp. 103359. Date of Electronic Publication: 2024 Oct 04.